ViraCor, IBT to Merge | GenomeWeb

ViraCor, IBT to Merge

NEW YORK (GenomeWeb News) – ViraCor Laboratories and IBT Laboratories announced today that they will merge to form a new specialty diagnostic testing lab.

The merger will combine ViraCor's molecular diagnostic testing services with IBT's focus on immunology and allergy testing. Terms of the merger were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.